UK markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
82.73+1.16 (+1.42%)
At close: 04:00PM EDT
82.62 -0.11 (-0.13%)
After hours: 05:47PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 49.13B
Enterprise value 48.60B
Trailing P/E 32.60
Forward P/E 31.55
PEG ratio (5-yr expected) 3.93
Price/sales (ttm)9.23
Price/book (mrq)8.33
Enterprise value/revenue 9.03
Enterprise value/EBITDA 27.16

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-33.72%
S&P500 52-week change 3-10.89%
52-week high 3131.10
52-week low 367.13
50-day moving average 378.87
200-day moving average 384.54

Share statistics

Avg vol (3-month) 33.58M
Avg vol (10-day) 33.17M
Shares outstanding 5606.1M
Implied shares outstanding 6N/A
Float 8602.8M
% held by insiders 10.84%
% held by institutions 187.32%
Shares short (14 Mar 2023) 416.94M
Short ratio (14 Mar 2023) 44.31
Short % of float (14 Mar 2023) 42.81%
Short % of shares outstanding (14 Mar 2023) 42.78%
Shares short (prior month 14 Feb 2023) 411.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 331 May 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 28.28%
Operating margin (ttm)33.29%

Management effectiveness

Return on assets (ttm)13.34%
Return on equity (ttm)26.14%

Income statement

Revenue (ttm)5.38B
Revenue per share (ttm)8.69
Quarterly revenue growth (yoy)1.40%
Gross profit (ttm)4.3B
Net income avi to common (ttm)1.52B
Diluted EPS (ttm)2.44
Quarterly earnings growth (yoy)18.80%

Balance sheet

Total cash (mrq)1.22B
Total cash per share (mrq)2
Total debt (mrq)691.3M
Total debt/equity (mrq)11.90
Current ratio (mrq)3.03
Book value per share (mrq)9.55

Cash flow statement

Operating cash flow (ttm)1.22B
Levered free cash flow (ttm)933.04M